Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

Fig. 3

One-way sensitivity analysis of HZ/su for vaccination of 70-year-olds. The threshold vaccine cost per series is the maximum cost to remain below a threshold of €20,000 per QALY gained. a Deterministic sensitivity analysis showing the impact of parameter uncertainty by using the lower (dark grey) and upper (light grey) ranges that were based on the 95% confidence intervals of the input parameters. b Scenario analysis showing the impact of structural uncertainty by using other plausible model inputs. GP, general practitioner; HC, healthcare; HCP, healthcare payer; HZ, herpes zoster; HZ/su, herpes zoster subunit vaccine; PHN, post-herpetic neuralgia; QALY, quality-adjusted life year; VE, vaccine efficacy

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us